98%
921
2 minutes
20
Background: Lifestyle interventions and low glycemic diets have potential in diabetes prevention. However, dietary monitoring relies on self-report, which is prone to under-reporting. This observational study investigated the correlation between continuous glucose monitoring (CGM) metrics and glycemic load (GL) or daily macronutrients consumption.
Methods: Based on one week of CGM data, actigraphy measurements, and food diaries, we investigated correlations between GL per meal, and 19 CGM metrics, selected based on 20 studies identified via a systematic literature review. Furthermore, we generated linear mixed models to predict GL and macronutrients intake using moderately correlated CGM metrics.
Results: Forty-eight healthy participants (27 women, average age of 28.2 years, average body mass index (BMI) of 23.4 kg/m) were included. We found significant positive moderate correlations ( < .0004) between GL and area under the curve (ρ = 0.40, two-hour window), relative amplitude (ρ = 0.40, three hours and ρ = 0.42, four hours), standard deviation (SD) (ρ = 0.41, four hours), and variance (ρ = 0.43, four hours). Significant positive moderate correlations ( < .0004) were observed between carbohydrate and SD (ρ = 0.45), variance (ρ = 0.44), and mean amplitude of glycemic excursions (MAGE) (ρ = 0.40) over 24 hours. We obtained one valid mixed linear model for predicting GL from CGM metrics obtained two hours after food intake. A second model predicted energy intake using moderately correlated CGM metrics, body composition, sleep duration, and physical activity.
Conclusion: We demonstrated moderate correlations between GL and CGM metrics in healthy populations. These CGM metrics were successfully used to predict GL or energy intake.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12343543 | PMC |
http://dx.doi.org/10.1177/19322968251361555 | DOI Listing |
Diabetes Res Clin Pract
September 2025
Health Education Department, and Department of Endocrinology and Diabetes, Diabetes Treatment Center, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
Background: Despite advances, glycemic control in people with type 2 diabetes (PwT2D) treated with oral antidiabetic medications (ADMs) often remains suboptimal. Continuous glucose monitoring (CGM) has shown promise in diabetes management, offering real-time insights into glucose trends. This study evaluates the impact of transitioning from conventional self-monitoring of blood glucose (SMBG) to CGM on glycemic outcomes and self-management in PwT2D receiving oral ADMs.
View Article and Find Full Text PDFDiabetes Technol Ther
September 2025
Diabetes Technol Ther
September 2025
Department of Genetics, Stanford University, Stanford, California, USA.
Continuous glucose monitoring (CGM) devices provide real-time actionable data on blood glucose levels, making them essential tools for effective glucose management. Integrating blood glucose data with food log data is crucial for understanding how dietary choices impact glucose levels. Despite their utility, many CGM applications lack integration with other external services, such as food trackers, and do not generate useful glycemic variability (GV) metrics or advanced visualizations.
View Article and Find Full Text PDFDiabetes Metab J
September 2025
Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
This study evaluated whether a stage 4 smart insulin pen (SIP) provides superior glycemic control compared with a traditional insulin pen (TIP) in individuals with intensively insulin-treated diabetes. Forty-two adults with continuous glucose monitoring (CGM), multiple daily insulin injections, and no prior SIP use were included. After diabetes self-management education (DSME), the SIP group (n=21) initiated SIP, whereas the TIP group (n=21) continued their usual regimens.
View Article and Find Full Text PDFBMJ Open
September 2025
Department of Endocrinology and Nephrology, Nordsjællands Hospital, Hillerød, Capital Region of Denmark, Denmark.
Introduction: Continuous glucose monitoring (CGM) provides real-time glucose data for people with diabetes. However, detailed knowledge of its use in daily life remains limited. We aim to investigate the interaction between people with type 1 diabetes (T1D) and their CGM data and the impact of the interaction on glycaemia and diabetes distress.
View Article and Find Full Text PDF